Hoth Therapeutics, Inc. (HOTH:NASDAQ) closed at $1.36 on June 8, 2026, unchanged on the day. The stock trades 44.5% below its 52-week high of $2.45 and 177.9% above its 52-week low of $0.489. Hoth Therapeutics, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since October 22, 2025, HOTH closed higher on 66 days (26%). Its best day was May 27, 2026 (+92.01%) and its worst was April 1, 2026 (-34.86%). The stock moved 10% or more in a single session 13 times. It opened at least 5% above the previous day's high 4 times.
Hoth Therapeutics Inc is a development stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
Find more stocks like HOTH with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.